The Food and Drug Administration (FDA) has approved a new once-daily pill that could make HIV treatment easier for some people living with the virus. Bixlenvo, developed by Gilead Sciences, combines bictegravir, the active ingredient in Biktarvy, with lenacapavir, a newer class of HIV medication called a capsid inhibitor, according to Advocate.The approval is specifically for [...]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.